Cyclopharm Limited (CYC.AX)
AUD 1.1
(6.31%)
AUD 1.1
(6.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 27.13 Million | 23.21 Million | 17.7 Million | 14.67 Million | 14.07 Million | 13.4 Million |
| Cost of Revenue | 22.64 Million | 17.27 Million | 14.5 Million | 12.59 Million | 9.21 Million | 7.75 Million |
| Gross Profit | 4.49 Million | 5.94 Million | 3.2 Million | 2.07 Million | 4.86 Million | 5.64 Million |
| Operating Expenses | 13.38 Million | 13.21 Million | 9.63 Million | 10.16 Million | 10.75 Million | 8.18 Million |
| Selling, General and Administrative Expenses | 16.04 Million | 9.77 Million | 7.97 Million | 6.62 Million | 6.56 Million | 4.96 Million |
| Research and Development Expenses | 3.68 Million | 3.43 Million | 1.66 Million | 3.53 Million | 4.19 Million | 3.21 Million |
| Other Expenses | - | 1.76 Million | 2.69 Million | 2.84 Million | 4.09 Million | 2.48 Million |
| Cost and Expenses | 36.02 Million | 30.49 Million | 24.13 Million | 22.75 Million | 19.96 Million | 15.94 Million |
| Operating Income | -9.22 Million | -7.27 Million | -6.43 Million | -8.08 Million | -5.89 Million | -2.53 Million |
| Interest Expense | 215.99 Thousand | 265.92 Thousand | 89.31 Thousand | 207.85 Thousand | 280.25 Thousand | 26.12 Thousand |
| Income Tax Expense | 511.07 Thousand | -1.05 Million | -1.59 Million | -2.8 Million | -2.44 Million | -1.96 Million |
| Earnings before Tax | -4.18 Million | -7.66 Million | -6.63 Million | -8.84 Million | -5.35 Million | -2 Million |
| Net Income | -4.7 Million | -6.61 Million | -5.04 Million | -6.04 Million | -2.91 Million | -35.45 Thousand |
| Earnings Per Share Basic | -0.05 | -0.07 | -0.06 | -0.08 | -0.04 | -0.00 |
| Earnings Per Share Diluted | -0.05 | -0.07 | -0.06 | -0.08 | -0.04 | -0.00 |
| Weighted Average Shares Outstanding | 92.66 Million | 92.17 Million | 89.57 Million | 76.59 Million | 68.12 Million | 67.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.66 Million | 92.17 Million | 89.57 Million | 76.59 Million | 68.12 Million | 67.97 Million |
| Gross Margin | 0.17 | 0.26 | 0.18 | 0.14 | 0.35 | 0.42 |
| EBIT Margin | -0.11 | -0.27 | -0.32 | -0.49 | -0.35 | -0.15 |
| Profit Margin | -0.17 | -0.28 | -0.28 | -0.41 | -0.21 | -0.00 |
| EBITDA | -3.03 Million | -5.35 Million | -4.19 Million | -4.86 Million | -4.07 Million | -1.46 Million |
| Earnings Before Tax Margin | -0.34 | -0.31 | -0.36 | -0.55 | -0.42 | -0.19 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 12.27 Million | 10.61 Million | 27.13 Million | 15.72 Million | 11.8 Million | 23.21 Million |
| Cost of Revenue | 13.82 Million | 11.54 Million | 22.64 Million | 11.33 Million | 9.25 Million | 17.27 Million |
| Gross Profit | -1.54 Million | -930.7 Thousand | 4.49 Million | 4.38 Million | 2.55 Million | 5.94 Million |
| Operating Expenses | 6.77 Million | 5.86 Million | 13.38 Million | 7.27 Million | 7.72 Million | 13.21 Million |
| Selling, General and Administrative Expenses | 6.56 Million | 5.26 Million | - | 4.18 Million | 4.56 Million | - |
| Research and Development Expenses | 209.46 Thousand | 606.27 Thousand | - | 3.08 Million | 3.16 Million | - |
| Other Expenses | - | - | 5.56 Million | - | - | 1.76 Million |
| Cost and Expenses | 20.59 Million | 17.41 Million | 36.02 Million | 18.6 Million | 16.98 Million | 30.49 Million |
| Operating Income | -8.32 Million | -6.79 Million | -8.88 Million | -2.88 Million | -5.17 Million | -7.27 Million |
| Interest Expense | 127.46 Thousand | 106.07 Thousand | 23.93 Thousand | 109.92 Thousand | 100.81 Thousand | 265.92 Thousand |
| Income Tax Expense | 32.04 Thousand | 275.36 Thousand | 511.07 Thousand | 235.7 Thousand | -1.3 Million | -1.05 Million |
| Earnings before Tax | -7.47 Million | -1.53 Million | -4.18 Million | -2.65 Million | -5.35 Million | -7.66 Million |
| Net Income | -7.5 Million | -1.8 Million | -4.7 Million | -2.89 Million | -4.04 Million | -6.61 Million |
| Earnings Per Share Basic | -0.08 | -0.02 | - | -0.03 | -0.04 | - |
| Earnings Per Share Diluted | -0.08 | -0.02 | - | -0.03 | -0.04 | - |
| Weighted Average Shares Outstanding | 95.86 Million | 94.09 Million | 92.66 Million | 91.79 Million | 93.05 Million | 92.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 95.86 Million | 94.09 Million | 92.66 Million | 91.79 Million | 93.05 Million | 92.17 Million |
| Gross Margin | -0.13 | -0.09 | 0.17 | 0.28 | 0.22 | 0.26 |
| EBIT Margin | -0.62 | -0.60 | - | -0.15 | -0.40 | - |
| Profit Margin | -0.61 | -0.17 | -0.17 | -0.18 | -0.34 | -0.28 |
| EBITDA | -7.55 Million | -6.32 Million | - | -2.41 Million | -4.68 Million | - |
| Earnings Before Tax Margin | -0.68 | -0.64 | -0.33 | -0.18 | -0.44 | -0.31 |
BAC-PM
PRN
7360
NAHARSPING
7841
PERI